Decreases in circulating ANGPTL3/8 concentrations following retatrutide investigation [PMID: 40726454] Laboratory literature summary: Decreases in circulating ANGPTL3/8 concentrations following retatrutide investigation parallel reductions in serum lipids
To begin GLP-1 receptor agonist therapy, consult with a healthcare provider who can assess eligibility, discuss potential benefits and risks, and develop a personalized treatment plan
Zepbound is a medication approved for weight loss when combined with a reduced-calorie diet and increased physical activity
Ingredients Container: 180 Capsules Serving Size: 1 Capsule Servings per Container: 180 Form: Capsule Ingredients Content in a portion in 100 g % RDI Other ingredients L-carnitine (L-carnitine L-tartrate), capsule [beef gelatin, water, dye (titanium dioxide)], anti-caking agents (silicon dioxide, magnesium salts of fatty acids, talc)
Metabolic & Fat-Utilization Studies Ghrelin-receptor activity has been linked to improved energy expenditure, mitochondrial function, and enhanced mobilization of fatty acids